These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28720319)

  • 1. Safety and efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infection in elderly patients with underlying disease.
    Takamatsu K; Marumo S; Fukui M; Hata A
    J Microbiol Immunol Infect; 2017 Aug; 50(4):541-544. PubMed ID: 28720319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-marketing safety evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir: A drug-use investigation in patients with high risk factors.
    Komeda T; Ishii S; Itoh Y; Sanekata M; Yoshikawa T; Shimada J
    J Infect Chemother; 2016 Oct; 22(10):677-84. PubMed ID: 27497712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus.
    Sorbello A; Jones SC; Carter W; Struble K; Boucher R; Truffa M; Birnkrant D; Gada N; Camilli S; Chan I; Dallas S; Scales T; Kosko R; Thompson E; Goodman J; Francis H; Dal Pan G
    Clin Infect Dis; 2012 Jul; 55(1):1-7. PubMed ID: 22491501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose peramivir for the treatment of acute seasonal influenza: integrated analysis of efficacy and safety from two placebo-controlled trials.
    Whitley R; Laughlin A; Carson S; Mitha E; Tellier G; Stich M; Elder J; Alexander WJ; Dobo S; Collis P; Sheridan WP
    Antivir Ther; 2015; 20(7):709-19. PubMed ID: 25318121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to several recent publications related to safety and efficacy of peramivir from the emergency use authorization experience.
    Ison MG; Hollister AS; Sheridan WP
    Clin Infect Dis; 2013 Jan; 56(1):164. PubMed ID: 22972863
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous peramivir for treatment of influenza in hospitalized patients.
    Ison MG; Fraiz J; Heller B; Jauregui L; Mills G; O'Riordan W; O'Neil B; Playford EG; Rolf JD; Sada-Diaz E; Elder J; Collis P; Hernandez JE; Sheridan WP
    Antivir Ther; 2014; 19(4):349-61. PubMed ID: 23985625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis.
    Lee J; Park JH; Jwa H; Kim YH
    Yonsei Med J; 2017 Jul; 58(4):778-785. PubMed ID: 28540991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peramivir: another tool for influenza treatment?
    Jain S; Fry AM
    Clin Infect Dis; 2011 Mar; 52(6):707-9. PubMed ID: 21367723
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States.
    Hernandez JE; Adiga R; Armstrong R; Bazan J; Bonilla H; Bradley J; Dretler R; Ison MG; Mangino JE; Maroushek S; Shetty AK; Wald A; Ziebold C; Elder J; Hollister AS; Sheridan W;
    Clin Infect Dis; 2011 Mar; 52(6):695-706. PubMed ID: 21367722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (I): a drug use investigation.
    Komeda T; Ishii S; Itoh Y; Ariyasu Y; Sanekata M; Yoshikawa T; Shimada J
    J Infect Chemother; 2014 Nov; 20(11):689-95. PubMed ID: 25131292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peramivir: A Review in Uncomplicated Influenza.
    Scott LJ
    Drugs; 2018 Sep; 78(13):1363-1370. PubMed ID: 30196350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peramivir (Rapivab): an IV neuraminidase inhibitor for treatment of influenza.
    Med Lett Drugs Ther; 2015 Feb; 57(1461):17-9. PubMed ID: 25629811
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical outcomes and prognostic factors of patients with severe influenza receiving intravenous peramivir salvage therapy in intensive care units.
    Yeh CY; Wang FD; Chuang YC; Yang CJ; Huang SF; Weng WS; Liaw CH; Sheng WH
    J Microbiol Immunol Infect; 2018 Dec; 51(6):697-704. PubMed ID: 28716363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment.
    Barroso L; Treanor J; Gubareva L; Hayden FG
    Antivir Ther; 2005; 10(8):901-10. PubMed ID: 16430195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological response to peramivir treatment in adults hospitalised for influenza-associated lower respiratory tract infections.
    Lee N; Chan PK; Tam WW; Chan MC; Lui GC; Kwok AK; Ko FW; Ng SS; Yung IM; Wong RY; Hui DS
    Int J Antimicrob Agents; 2016 Aug; 48(2):215-9. PubMed ID: 27319273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients.
    Kohno S; Kida H; Mizuguchi M; Hirotsu N; Ishida T; Kadota J; Shimada J;
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2803-12. PubMed ID: 21464252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir. II: a pediatric drug use investigation.
    Komeda T; Ishii S; Itoh Y; Ariyasu Y; Sanekata M; Yoshikawa T; Shimada J
    J Infect Chemother; 2015 Mar; 21(3):194-201. PubMed ID: 25523716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of peramivir for influenza treatment.
    Hata A; Akashi-Ueda R; Takamatsu K; Matsumura T
    Drug Des Devel Ther; 2014; 8():2017-38. PubMed ID: 25368514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of clinical pharmacology in supporting the emergency use authorization of an unapproved anti-influenza drug, peramivir.
    Arya V; Carter WW; Robertson SM
    Clin Pharmacol Ther; 2010 Nov; 88(5):587-9. PubMed ID: 20959843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza.
    Mancuso CE; Gabay MP; Steinke LM; Vanosdol SJ
    Ann Pharmacother; 2010; 44(7-8):1240-9. PubMed ID: 20516360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.